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HUMAN TOXOCARIASIS: CONTRIBUTION BY BRAZILIAN RESEARCHERS
Pedro Paulo CHIEFFI(1,2), Sérgio Vieira dos SANTOS(1), Maisa Leite de QUEIROZ(1,2) & Susana A. Zevallos LESCANO(1)
SUMMARY
In the present paper the main aspects of the natural history of human infection by Toxocara larvae that occasionally result in the 
occurrence of visceral and/or ocular larva migrans syndrome were reviewed. The contribution by Brazilian researchers was emphasized, 
especially the staff of the Tropical Medicine Institute of São Paulo (IMT).
KEYWORDS: Toxocara; Toxocara canis; Visceral and ocular larva migrans.
INTRODUCTION
Human infection by larvae of Toxocara is currently considered an 
important zoonosis and the principal cause of visceral larva migrans and 
other related syndromes.
More than 50 years ago, while analyzing liver biopsies taken from 
three children suffering from hepatomegaly, respiratory symptoms, anemia 
and very elevated eosinophilia, BEAVER et al.13,15 observed Toxocara 
canis larvae within eosinophilic granulomata. Thus, they described a new 
syndrome called visceral larva migrans (VLM), caused by the erratic and 
prolonged migration principally by Toxocara and, occasionally, by other 
nematode larvae, in unusual hosts, denominated paratenic hosts, in whose 
tissues and organs the larvae remain alive and viable for long periods. 
In 1956, NICHOLS76 identified Toxocara canis larvae in enucleated eye 
sections from certain patients supposedly presenting retinoblastoma, 
describing the clinical and anatomopathological features of ocular larva 
migrans (OLM). Approximately three decades later, other aspects of the 
syndrome known as covert toxocariasis (CT), characterized by abdominal 
pain, coughing, headache and normal or mildly elevated eosinophilia, 
with the presence of serum anti-Toxocara antibodies, were described12,98.
The great majority of larvae identified in human cases of VLM or 
OLM were classified as belonging to T. canis, although other species 
of the genus Toxocara have sporadically been detected in biopsies 
as etiological agents, as well as other nematode species, such as 
Gnathostoma spinigerum and Ancylostoma caninum84. It is fairly common 
in the medical literature to consider the various forms of visceral or ocular 
larva migrans as human toxocariasis infection.
Although the majority of humans infected by Toxocara larvae present 
an asymptomatic course, some symptomatic patients can present important 
disease. SMITH et al.96 recently reviewed the principal symptoms and 
signs present in the three clinical types of human toxocariasis as follow:
VLM: fever, pallor, malaise, irritability, weight loss, cutaneous 
rash, hepatomegaly, respiratory and nervous disturbs, myocarditis, 
hypergammaglobulinemia, leukocytosis and eosinophilia, elevated anti-A 
and anti-B isohemagglutinins;
OLM: visual loss, strabismus, retinal granuloma and detachment, 
endophthalmitis, chorioretinitis, uveitis;
CT: coughing, abdominal pain, headache, sleep and behavioral disturbances.
The aim of this paper is to review the principal aspects of the natural 
history of Toxocara human infection, emphasizing the contribution of 
Brazilian researchers, especially those working at the Tropical Medicine 
Institute of São Paulo.
Toxocara canis infection in dogs: Dogs and other canid species are the 
natural hosts of Toxocara canis and can be infected by several mechanisms: 
ingestion of Toxocara canis embryonated eggs, transplacentary or 
transmammary transmission of third stage larvae, predation of infected 
paratenic hosts (principally rodents) and, finally, by ingestion of Toxocara 
canis young adults sometimes eliminated by infected pets.
The type of larval migration (tracheal or somatic) presented by 
infected dogs depends principally on the animal’s age. Young dogs, less 
than five to six months old, usually present tracheal larval migration, 
resulting in the presence of intestinal adult worms, responsible for fecal 
egg delivering; older dogs, previously infected by transplacentary or 
transmammary mechanisms, present somatic larval migration, resulting in 
encysted third stage larvae in their tissues. In this case pregnant females 
may transmit Toxocara larvae to their progeny80. 
As human toxocariasis is a consequence of soil contamination by 
Toxocara canis eggs, the frequency of dog infection by this ascarid should 
be considered a good index for evaluating human risk of infection. Several 
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surveys conducted in numerous locations in Brazil showed variable 
prevalence rates for Toxocara canis infection in dog fecal samples, as 
shown in Table 1.
Frequency of human infection by Toxocara: Since the 1970s, 
it has been established that the essential factors for the occurrence of 
human infection by Toxocara and, consequently by VLM, are present 
in Brazil: a large number of dogs, mainly strays, infected with T. canis 
and frequent soil contamination by eggs of this ascarid24,25,44. However, 
only one decade later, reports on Toxocara human infection began to 
appear28 and from the 1990s onward, several papers had been published 
reporting the presence of human infection in many Brazilian regions, 
with variable infection rates (Table 2).
Serum samples from 1,023 individuals resident in Lima (Peru) 
were examined for anti-Toxocara antibodies in the IMT Laboratory of 
Helminthology, showing a frequency rate of 7.33%63.
Almost all the surveys on the presence of anti-Toxocara antibodies in 
human sera were designed as transverse studies, which only permit the 
evaluation of frequency and, occasionally, the prevalence of infection. 
However, in 2003, ANARUMA et al.8 estimated the incidence rate as 
17.9% in the outskirts of Campinas, in the State of São Paulo, based on 
two surveys conducted in January 1999 and January 2000.
Soil contamination by Toxocara eggs: As already stated, soil 
contamination by Toxocara eggs is frequent in almost all Brazilian regions 
where soil samples have been examined. Contact with soil contaminated 
by Toxocara eggs is considered an important risk factor for the occurrence 
of human infection, as is domiciliary ownership of dogs29. In Table 3, the 
results of the principal surveys on soil contamination by Toxocara eggs 
conducted in some Brazilian locations are summarized.
Eggs of ascarids, and particularly of Toxocara, are highly resistant to 
environmental conditions, remaining viable and infective for long periods 
Table 1
 Infection rates by Toxocara canis in dog fecal samples examined in Brazilian locations
Authors/year Local Samples % Positivity
CHIEFFI & MÜLLER, 197624 Londrina, PR 158 37.0
GENNARI et al.,199949 São Paulo, SP 353 8.5
OLIVEIRA-SEQUEIRA et al., 200279 São Paulo, SP 271 5.5
MURADIAN et al., 200573 São Paulo, SP 41 39.0
BLAZIUS et al., 200516 Itapema, SC 158 14.5
TÁPARO et al., 200697 Araçatuba, SP 401 20.7
LABRUNA et al., 200659 Monte Negro, RO 95 18.9
DE VASCONCELLOS et al., 200641 Rio de Janeiro, RJ 204 8.8
KATAGIRI et al., 200858 São Paulo, SP 138 8.7
Table 2
Frequency of human infection by Toxocara in some Brazilian regions
Authors/year Local Number of samples Frequency (%) of positivity
CHIEFFI et al., 199028 5 towns in the State of São Paulo 2,025 3.72
VIRGINIA et al., 1991101 Pernambuco 54 40.0
CASEIRO, 199622 Santos, SP 2,056 24.7
MATOS et al., 199770 Campo Grande, MS 454 35.5
MOREIRA-SILVA et al., 199872 Vitória, ES 100 39.0
ANARUMA FILHO et al., 20027 Campinas, SP 138 23.9
CAMPOS JR. et al., 200320 Brasilia, DF 602 21.8
ALDERETE et al., 20036 São Paulo, SP 399 38.8
COELHO et al., 200432 Sorocaba, SP 180 38.3
AGUIAR-SANTOS et al., 20042 Recife, PE 386 39.4
COELHO et al., 200533 Guararapes, PE 215 12.1
TEIXEIRA et al., 200699 Uberlândia, MG 242 8.7
FERREIRA et al., 200745 State of Acre 606 21.5
ELEFANT et al., 200843 State of Acre 403 26.8
PRESTES-CARNEIRO et al., 200883 Teodoro Sampaio, SP 79 21.5
SANTOS et al., 200991 Goiânia, GO 1,131 18.9
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in the soil. Under experimental conditions LESCANO et al.63 reported 
the retention of infectivity of at least 11 months for Toxocara canis eggs 
maintained at 28 oC in a 2% formalin solution. In addition, CHUNG et al.30 
observed a greater survival rate when the eggs were maintained at 4 oC. 
However, certain environmental factors can influence the evolution of 
Toxocara eggs in the soil48,54. Under experimental conditions, QUEIROZ 
et al.85 concluded that low temperatures, lack of luminosity and low levels 
of humidity are deleterious to the development of Toxocara canis eggs.
There are some reports indicating better evolution rates for ascarid 
and especially for Toxocara eggs in clayey soils rather than in sandy 
type soils14. However, in sandy soils experimentally contaminated with 
Toxocara canis eggs, CHIEFFI et al.27 observed greater facility in the 
recovery of eggs compared to clayey soils. 
Evaluating the presence and viability of Toxocara eggs in soil 
samples, examined monthly in Londrina (Paraná State) over a one year 
period, CHIEFFI & MÜLLER24 observed the occurrence of eggs in 
almost all samples; however, only in the periods between May-June 
and September-December was the observation of viable eggs frequent. 
QUEIROZ et al.86 also observed two peaks of higher frequency of soil 
contamination by Toxocara canis eggs (February-May 2004 and April-
July 2005) in an 18-month survey conducted in the southern region of 
the municipality of São Paulo (State of São Paulo), during the period 
comprising February 2004 to July 2005. Research conducted in other 
countries also showed periods of higher soil contamination by Toxocara 
eggs during the year88,93.
Experimental toxocariasis in the murine model: The mouse is an 
excellent laboratory host to study experimental infection by T. canis in 
animals, because it tolerates heavy infections for long periods without 
suffering notable alterations and the larvae follow the enteric-pulmonary-
somatic cycle with signs and symptoms similar to those produced in 
humans. This rodent can be also infected with other parasites, permitting 
the study of concomitant infections75.
In the mouse, the migratory route includes two phases: a visceral 
phase, during the first week, reaching the liver and lungs, with maximum 
peaks on postinfection days (PIDs) 2 and 3 in order to disseminate 
throughout all the body cavities and enter the second, myotropic-
neurotropic phase that occurs approximately on PID 7, within muscle 
and brain tissues1. LESCANO et al.65 confirmed similar results in Rattus 
norvegicus.
Data regarding the larval migration of T. canis in the mouse depend 
on the experimental conditions, which are often different concerning 
several important factors: inoculum size, larval recovery method, parasite 
strain and mouse strain used53.
Research in Brazil: CHIEFFI et al.26 studied the persistence of 
anti-Toxocara antibodies for one year in three schedules of T. canis-
infected BALB/c mice, simulating a very common situation, that of the 
frequent occurrence of reinfection in natural conditions. In this assay, 
they demonstrated the persistence of antibodies against Toxocara at high 
levels at least six months after the experimental infection of mice with 
low doses of embryonated eggs from this ascarid, when the infection was 
obtained by either single administration of 200 T. canis eggs or three 
doses of 50 eggs administered on days 1, 5 and 8. Thirty days after the 
first dose of infective eggs, the mice were already showing high serum 
levels anti-Toxocara antibodies and the highest antibody levels were 
determined on PID 50.
The murine model of T. canis has also been used to understand the 
role of cytokines in the infection, as reported by PECINALI et al.81. In 
their work, they investigated the kinetics of tissue distribution of L2 
larvae in various organs and also analyzed blood and bronchoalveolar 
fluid (BAL) for levels of IL-6, IFN-γ, eotaxin and Regulated on Activation 
Normal T Cell Expressed and Secreted (RANTES) in the infected 
rodents. The researchers observed that liver, lung and kidney lesions 
correlated with larval migration as early as the first day of infection. 
After PID 7, larvae could also be detected in brain, skeletal muscle 
and heart tissues, indicating a biphasic migration pattern. Plasma and 
BAL of infected mice revealed increased inflammatory activity and an 
intense eosinophil migration was associated with increased levels of all 
the cytokines studied; thus, establishing a strong correlation between 
tissue lesions caused by the larval migration and increased plasma 
levels of proinflammatory cytokines as well as eosinophil chemotactic 
cytokines. They also described eotaxin and RANTES as potential factors 
responsible for the increased eosinophilic response that is characteristic 
of this infection.
In order to study eosinophil migration in mice after infection with T. 
canis, ANIBAL et al.9 treated mice with the leukotriene inhibitor MK886 
(1 mg/kg/day). Eosinophils in peripheral blood (PB), peritoneal cavity (PC) 
and bronchoalveolar lavage fluid (BAL) samples were counted between 
PIDs 3 and 36. Observation verified that T. canis infection induced systemic 
eosinophilia from PID 3, peaking on PIDs 6, 12 and 24 for PB, PC and 
BAL samples, respectively. More pronounced eosinophilia was observed 
in PB and PC samples than in BAL samples and MK886 downregulated 
eosinophilia in varying degrees in the different samples types. This data 
demonstrated that although systemic eosinophilia is triggered by T. canis 
infection, the inflammatory responses vary in each compartment.
RAYES et al.87 studied the relation between tropical pyomyositis and 
toxocariasis in Swiss mice that where infected with T. canis embryonated 
Table 3
Soil contamination by Toxocara eggs in public places in several 
Brazilian locations 
Authors/year Local Frequency (%) 
of positivity
CHIEFFI & MÜLLER,24,25 Londrina, PR 60.0
FERREIRA et al., 197644 Rio de Janeiro, RJ 41.6
CAMPOS et al., 198719 Goiânia, GO 66.6
ALCÂNTARA et al., 19895 Salvador, BA 24.8
COSTA-CRUZ et al., 199438 Uberlândia, MG 23.1
SANTARÉM et al., 199890 Botucatu, SP 17.5
COELHO et al., 200131 Sorocaba, SP 53.3
ANARUMA FILHO et al., 
20027
Campinas, SP 14.0
GUIMARÃES et al., 200555 Lavras, MG 69.6
SANTARÉM et al., 200889 Pontal do 
Paranapanema, SP
29.0
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eggs and Staphylococcus aureus, or with S. aureus alone, and examined 
for the presence of muscle abscesses. In this experimental study, muscle 
abscesses were more frequently observed in mice coinfected with T. 
canis and S. aureus. These results showed an association between 
toxocariasis and pyogenic abscesses of the skeletal muscle, suggesting 
that infection with this nematode is a cofactor in the development of 
tropical pyomyositis.
An assay to understand the immune response to T. canis pneumonia 
in mice with preweaning nutritional deprivation was conducted by 
MOREIRA & ROCHA71. The researchers worked with undernourished 
Swiss mice and paired controls that were infected with T. canis larvae at 
21 days of age. Liver retinol, retinyl palmitate and inflammatory infiltrate 
in the lungs were compared in both groups. Significantly lower levels of 
retinol and retinyl palmitate in liver tissue confirmed A hypovitaminosis 
in the nutritionally deprived mice. Histological analysis showed similar 
eosinophilic infiltration in both groups at day 3, but was significantly more 
severe in undernourished mice at PID 20. These findings indicated that 
preweaning undernourishment is associated with more severe inflammation 
in response to T. canis pneumonia and suggested that vitamin A deficiency 
that persists after nutritional rehabilitation, may contribute to the severity 
of T. canis infection. In summary, this work provided a model to observe 
how comorbidity of preweaning undernourishment and T. canis infection 
results in more severe lung inflammation.
FRANTZ et al.47 studied the coinfection T. canis and Mycobacterium 
tuberculosis in BALB/c mice. In coinfected mice, the BAL showed 
enhanced eosinophil levels with diminished neutrophil and mononuclear 
cell accumulation. However, coinfected mice had similar mycobacterial 
proliferation in their lungs accompanied by identical histopathological 
changes and similar cytokine/nitric oxide production compared with 
Mycobacterium-only infected mice, suggesting that T. canis infection does 
not necessarily lead to increased susceptibility to pulmonary tuberculosis.
Some assays were conducted on experimental murine toxocariasis 
and chemotherapy developed here, in Brazil: LESCANO et al.62 studied 
the effects of administration of either cyclosporine A or betamethasone 
15 days before or 45 days after experimental infection with T. canis 
on BALB/c mice. The parameters observed were: production of IgG 
anti-Toxocara antibodies and larval recovery at PID 90. A significant 
delay in the production of anti-Toxocara IgG antibodies was observed 
in all mice treated with cyclosporine A or betamethasone 15 days before 
infection. On the other hand, mice treated with cyclosporine A 15 days 
before infection, but not with betamethasone, showed a significantly 
higher number of trapped larvae of this ascarid in the tissues examined, 
indicating that the anthelmintic effect of cyclosporine A does not surpass 
the immunosuppressive effects when this drug is administered prior to 
infection with T. canis, while also suggesting that the use of both drugs 
would not significantly interfere in the immunodiagnosis of visceral 
larva migrans in humans.
LESCANO et al.61 studied the effects of treatment with ivermectin, 
mebendazole or thiabendazole on larval recovery of T. canis and on 
immune response in experimental infected BALB/c mice. At the end 
of the experiments, a significant decrease in larvae recovered from 
treated mice was observed compared to infected and untreated mice 
with no parasitological cure; confirming that the three drugs used in this 
experiment had similar efficacies.
Experiments in Rattus norvegicus, Wistar strain, have also been 
conducted: for the first time, LESCANO et al.65 recorded the recovery 
of T. canis larvae from tissues and organs of this rat up to PID 60. They 
concluded that the recovery of live larvae of the parasite from different 
tissues of the rat indicated that this rodent possesses the conditions to act 
as paratenic host of T. canis and may transfer these larvae to carnivorous 
animals due to the prey-predator relationship, serving as an important 
factor in the circulation and maintenance of toxocariasis in nature. 
SANTOS et al.92 performed the larval recovery of Toxocara cati in 
experimentally infected R. norvegicus and observed some differences in 
the migration of this ascarid compared with studies involving T. canis65: 
larval migration to the brain was less expressive in the case of T. cati and 
R. norvegicus does not appear to be a good model for ocular larva migrans 
compared with other rodent species4. However, this work reinforced the 
thesis that R. norvegicus is a potential reservoir for Toxocara spp. in the 
environment.
This year, CHIEFFI et al.23 investigated the effect of muscular 
migration of T. canis larvae on the muscular strength of infected R. 
norvegicus. The results obtained in this assay reinforced the hypothesis 
that infection by T. canis induces a decrease in muscular force and, thus, 
facilitates ascarid transmission via the prey-predator relationship. 
Clinical features and laboratorial diagnosis of human 
toxocariasis: The principal clinical syndromes of human toxocariasis 
(visceral larva migrans and ocular larva migrans) were described 
more than 50 years ago. In the first case, fever, respiratory alterations, 
abdominal pain, hepatomegaly and eosinophilia are the main signs and 
symptoms determined in symptomatic patients. In patients with ocular 
larva migrans, visual impairment is usually unilateral and the principal 
causes of visual loss are fibrous traction bands, endophthalmitis, macular 
lesions and pars planitis50.
More recently, unusual forms of the disease had been described and 
denominated “covert toxocariasis”, whose main features are abdominal 
pain, headache, coughing and hepatomegaly. Despite the high anti-
Toxocara antibody titers determined in these patients the level of blood 
eosinophils is sometimes not very high12,98.
While studying 40 children with high eosinophilia and the presence 
of serum anti-Toxocara antibodies in São Paulo, JACOB56 verified 
that 26 presented clinical manifestations of visceral larva migrans. 
The following symptoms and signs were observed in these patients: 
pulmonary manifestations (50%), fever (15.4%), joint manifestations 
(7.7%) and other alterations (22.8%).
Clinical diagnosis: The presumptive diagnosis of VLM or OLM is 
generally based on clinical signs, laboratory findings and a history of 
geophagia and contact with dogs. The clinical signs of toxocariasis are 
not specific and differential diagnosis includes other parasitic diseases 
characterized by hypereosinophilia, such as allergic reactions, asthma, 
eosinophilia, leukemia, as well as other helminthiasis, such as filariasis 
or acute schistosomiasis. Peripheral sanguineous eosinophilia has been 
constantly associated with VLM. In contrast, in patients with OLM, this 
laboratorial finding is frequently absent52, probably due to low larva 
numbers. In some patients with “covert toxocariasis”, eosinophilia may 
be absent. Promising results have been achieved in certain cases with the 
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use of image techniques at the location of granulomatous lesions caused 
by larvae of Toxocara11. 
Anatomopathological diagnosis: A definitive diagnosis of 
toxocariasis is possible using histopathological examination and 
morphological and morphometric identification of second stage larvae 
in tissue samples or by PCR for the detection of parasitic DNA in the 
tissue. However, the difficulty of obtaining biopsy material, much less 
material containing larvae, frustrates this type of diagnosis68,94. The use 
of immunohistochemical techniques in the analysis of liver biopsy17 
can permit larval antigen location in the histological sections examined. 
Such difficulties in the identification of Toxocara larvae stimulated the 
development of diagnostic immunological techniques that have become 
commonly used in the laboratory routine.
Immunodiagnosis: In most cases, laboratorial diagnosis depends on 
the demonstration of specific anti-Toxocara antibodies in the serum or 
ocular fluid of patients suspected of infection. Different immunological 
tests have been described: intradermal reactivity, complement fixation, 
bentonite flocculation, indirect hemagglutination, immunodiffusion, 
larvae immunoprecipitation, direct or indirect immunofluorescence, 
immunoenzymatic test (ELISA) and radioimmunoassay57. The most 
commonly used antigens in these tests are somatic extracts of adult worms 
or larvae, sections of worms or larvae and metabolic products of larvae 
maintained in culture. Due to differences in these antigenic preparations, 
the tests show wide variations in sensitivity and specificity. 
ELISA: The introduction of Immunoenzymatic assay (ELISA), 
based on the use of antigen extracted from larval culture of T. canis 
(antigen TES), resulted in a test with good specificity and sensitivity21,40,51. 
However, the evaluation of the true sensitivity and specificity of 
serological tests for toxocariasis in human populations is not possible due 
to lack of parasitological methods to diagnose the disease in a definitive 
form. Prior to the use of TES as a diagnostic antigen, much of the research 
on human Toxocara infection had been based on tests that used somatic 
hydrosoluble antigens derived from embryonated eggs, larvae or adults. 
Many of these antigens lacked sensitivity and expressed high degrees 
of cross reactivity with Ascaris and other geo-helminthes, such as S. 
stercoralis ancylostomids and T. trichiura95. Although the use of TES 
antigen has notably improved the efficiency of the test, this may not 
be specific enough when used in countries where this type of infection 
is prevalent66,86. Therefore, commercial “kits” that can not determine 
previous absorption of sera with antigens of these parasites can be of 
limited use in the diagnosis of toxocariasis in tropical countries.
In 1984, BACH-RIZZATI10 standardized the ELISA test for the 
detection of anti-Toxocara antibodies in Brazil, achieving similar results 
to both somatic and TES larva antigens. The author considered that after 
the absorption of the serum with Ascaris suum antigens, titers above 1:64 
were related to possible cases of toxocariasis in humans. CAMARGO 
et al.18 standardized the DOT-ELISA technique for the diagnosis of 
toxocariasis in Brazil and when they compared this technique with the 
ELISA test, they concluded that the DOT-ELISA presented advantages 
in relation to stability, the short duration of execution and lower cost. In 
2006, ELEFANT et al.42 standardized the ELISA IgG, IgA and IgE tests 
after using TES in the serological follow-up of patients with toxocariasis 
after chemotherapy in São Paulo. 
Immunoblotting: The study of the T. canis antigen by applying the 
techniques of SDS-PAGE and “Western blotting” (WB), conducted by 
AKAO et al.3, revealed eight different bands with molecular weights 
varying from 32 to 140 kDa and they observed differences between the 
acute and chronic phases of the infection, with the appearance of bands 
of low molecular weight after 26 weeks of infection. MAGNAVAL et 
al.67 used the WB technique to confirm positivity determined in human 
sera previously processed by the ELISA technique for IgG antibodies 
using antigen TES and achieved greater specificity with fractions of low 
molecular weight (24 to 35 kDa). The study by NUNES et al.78, using 
the Immunoblot test, determined that the 55-66 kDa antigenic complex 
was responsible for the cross reactivity between T. canis and A. suum; 
whereas LYNCH et al.66 had stated that strong cross reactivity between 
these two ascarids occurred in the 81 kDa antigen. In Brazil, JACOB56 
conducted a sequential study of patients with VLM and after treatment, 
WB showed the disappearance of certain fractions of high molecular 
weight (97-116 and 200-210 kDa), a pattern that could represent the 
individual behavior of the immune response of the patient and may be 
related to the slow fall in titers observed in the ELISA. 
Recombinant antigen: Limitations due to cross reactivity of 
the TES antigen with other helminth antigens and the difficulties 
in producing sufficient quantities of a standardized antigen has 
lead researchers to prepare a recombinant TES antigen for use in 
serodiagnosis. The recombinant antigens can provide a basis for 
serological tests with greater sensitivity and specificity compared 
with tests that use native TES. Two proteins of the recombinant 
TES have potential value in the serological diagnosis of human 
toxocariasis: the first, TES-30, is a recombinant protein of the second 
stage larva corresponding to the 30 kDa TES antigen. When used as 
an antigen in WB, this protein reacts specifically with sera of patients 
with toxocariasis, but not with sera of patients with Brugia malayi, 
dirofilariasis or ascariasis. Cross reactions with sera of infections 
with Anisakis have been observed, however, these were eliminated 
when the sera were previously absorbed with Anisakis antigen102. The 
second recombinant protein is the expression of the Tc-muc-1 gene that 
codifies the TES-120, which reacts with the sera of individuals with 
toxocariasis, but not with sera of patients with other helminthiasis or 
with protozoan infections46. COELHO et al.34 developed an ELISA test 
in Brazil using this immobilized recombinant antigen in solid phase 
consisting of pearls of polysiloxane/polyvinyl alcohol. Compared with 
the conventional test, this test presented a greater difference in density 
optics between the positive and negative results and the advantages of 
lower cost and greater facility in achieving the solid phase. The same 
group evaluated the prevalence of toxocariasis in North-eastern Brazil 
using the ELISA technique with the recombinant antigen33. 
Ocular toxocariasis: Serological diagnosis of OLM using the TES-
ELISA IgG is more challenging than serodiagnosis of VLM or “covert 
toxocariasis”, because the levels of antibodies in the serum are usually 
low or undetectable51 and eosinophilia is often absent. When OLM is 
suspected, aqueous or vitreous fluids are the best options for diagnostic 
samples. POLLARD et al.82 recommended that the ocular fluids must be 
diluted at a ratio of 1:8 before being tested, in comparison with a dilution 
of 1:32 for sera in suspected VLM cases, precisely because approximately 
10% of patients with clinical signs of OLM presented negative results 
in the ELISA test. 
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Neurotoxocariasis: Neurological syndromes observed during infection 
of the central nervous system (CNS) with Toxocara are generally unspecific 
and frequently, eosinophilia is a nonexistent sign. Imagenology in medicine 
is especially useful to study these patients. Magnetic resonance can detect 
granulomas located in the cortical or subcortical layers and these can appear 
as foci of high intensity protons. When associated with eosinophilia in the 
cerebrospinal fluid (CSF), such images are consistent with infection by 
Toxocara. Observation of larvae of the ascarid in the CSF, in brain tissue 
or meninges and/or a positive titer for anti-Toxocara antibodies in this 
fluid represents a decisive diagnosis72. In Espirito Santo, Brazil, MUSSO 
et al.74 examined CSF of children using ELISA IgG anti-Toxocara in order 
to determine whether any association existed between Toxocara and viral 
or bacterial infection in the CNS of the same and concluded that infection 
with this parasite is not associated with viral or bacterial meningitis or 
meningoencephalitis. Previously, COSTA-BARRA et al.36 had reported 
a case of VLM with a mixed form of clinical presentation combining 
neurological features associated with multiple joint aches and pulmonary 
alterations, which, after treatment with thiabendazole, evolved to complete 
clinical and laboratorial remission. 
RESUMO
Toxocaríase humana: contribuição dos pesquisadores brasileiros
São abordados os principais aspectos da história natural da infecção 
humana por larvas de Toxocara que pode resultar na ocorrência da síndrome 
de larva migrans visceral e/ou ocular. Deu-se destaque, principalmente, à 
contribuição de pesquisadores brasileiros e, em especial, aos pertencentes 
ao quadro do Instituto de Medicina Tropical de São Paulo.
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